Research / CALY / Fundamental state Inspectable configuration
State dimensions Filing 0000837465-23-000036 General Corporate
Debt relative to revenue 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
147.92% · OPTIONAL · VALID
Capex intensity 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
12.12% · OPTIONAL · VALID
Operating cash generation 85th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
23.98% · OPTIONAL · VALID
Revenue growth 10th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
5.27% · CORE · VALID
Inventory pressure 55th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
70.78% · OPTIONAL · VALID
Operating margin 35th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
7.09% · CORE · VALID
R&D intensity 50th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.17% · OPTIONAL · VALID
SBC intensity 85th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
1.31% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 38 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 8/8 normalized Level 3 Mar 31, 2022 8/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 8/8 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 130.84%
Current 147.92%
Delta 17.09% Capex Intensity Increased
Previous 11.97%
Current 12.12%
Delta 0.15% Cash Generation Increased
Previous 11.05%
Current 23.98%
Delta 12.93% Growth Decreased
Previous 5.74%
Current 5.27%
Delta -0.47% Inventory Pressure Decreased
Previous 71.19%
Current 70.78%
Delta -0.41% Profitability Decreased
Previous 9.83%
Current 7.09%
Delta -2.74% R And D Intensity Increased
Previous 1.86%
Current 2.17%
Delta 0.31% Sbc Intensity Increased
Previous 1.05%
Current 1.31%
Delta 0.26% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.